CLOVOXAMINE AND DOXEPIN IN MAJOR DEPRESSIVE DISORDER - A DOUBLE-BLIND CONTROLLED TRIAL

被引：7
|
作者：
LODGE, GJ
FREEMAN, HL
机构：
[1] HOPE HOSP,SALFORD M6 8HD,LANCS,ENGLAND
[2] ROUNDWAY HOSP,DEVIZES SN10 5DS,WILTS,ENGLAND
来源：
BRITISH JOURNAL OF PSYCHIATRY | 1986年 / 148卷
关键词：
D O I：
10.1192/bjp.148.6.718
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：718 / 721
页数：4
相关论文
共 50 条
  • [31] Cilostazol as an adjunctive treatment in major depressive disorder: a pilot randomized, double-blind, and placebo-controlled clinical trial
    Aida Khadivi
    Parnian Shobeiri
    Sara Momtazmaneh
    Farhaneh-Sadat Samsami
    Mohammadreza Shalbafan
    Elham Shirazi
    Shahin Akhondzadeh
    Psychopharmacology, 2022, 239 : 551 - 559
  • [32] LURASIDONE FOR MAJOR DEPRESSIVE DISORDER WITH MIXED FEATURES: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED 6 WEEK TRIAL
    Loebel, Antony
    Silva, Robert
    Mao, Yongcai
    Cucchiaro, Josephine
    Streicher, Caroline
    Suppes, Trisha
    SCHIZOPHRENIA BULLETIN, 2015, 41 : S320 - S321
  • [33] Effect of Etomidate Versus Thiopental on Major Depressive Disorder in Electroconvulsive Therapy, a Randomized Double-Blind Controlled Clinical Trial
    Abdollahi, Mohammad Hassan
    Izadi, Amir
    Hajiesmaeili, Mohammad Reza
    Ghanizadeh, Ahmad
    Dastjerdi, Ghasem
    Hosseini, Habib Allah
    Ghiamat, Mohammad Mehdi
    Abbasi, Hamid Reza
    JOURNAL OF ECT, 2012, 28 (01) : 10 - 13
  • [34] Paroxetine treatment in children and adolescents with major depressive disorder: A randomized, multicenter, double-blind, placebo-controlled trial
    Emslie, Graham J.
    Dineen Wagner, Karen
    Kutcher, Stan
    Krulewicz, Stan
    Fong, Regan
    Carpenter, David J.
    Lipschitz, Alan
    Machin, Andrea
    Wilkinson, Christel
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2006, 45 (06): : 709 - 719
  • [35] Omega-3 fatty acids in major depressive disorder - A preliminary double-blind, placebo-controlled trial
    Su, KP
    Huang, SY
    Chiu, CC
    Shen, WW
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, 13 (04) : 267 - 271
  • [36] Nutraceuticals for major depressive disorder- more is not merrier: An 8-week double-blind, randomised, controlled trial
    Sarris, Jerome
    Byrne, Gerard J.
    Stough, Con
    Bousman, Chad
    Mischoulon, David
    Murphy, Jenifer
    Macdonald, Patricia
    Adams, Laura
    Nazareth, Sonia
    Oliver, Georgina
    Cribb, Lachlan
    Savage, Karen
    Menon, Ranjit
    Chamoli, Suneel
    Berk, Michael
    Ng, Chee H.
    JOURNAL OF AFFECTIVE DISORDERS, 2019, 245 : 1007 - 1015
  • [37] Effect of AXS-05 (Dextromethorphan-Bupropion) in Major Depressive Disorder: A Randomized Double-Blind Controlled Trial
    Tabuteau, Herriot
    Jones, Amanda
    Anderson, Ashley
    Jacobson, Mark
    Iosifescu, Dan, V
    AMERICAN JOURNAL OF PSYCHIATRY, 2022, 179 (07): : 490 - 499
  • [38] Relapse prevention in adults with major depressive disorder treated with vilazodone: a randomized, double-blind, placebo-controlled trial
    Durgam, Suresh
    Gommoll, Carl
    Migliore, Raffaele
    Chen, Changzheng
    Chang, Cheng-Tao
    Aguirre, Michelle
    Thase, Michael E.
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2018, 33 (06) : 304 - 311
  • [39] Cilostazol as an adjunctive treatment in major depressive disorder: a pilot randomized, double-blind, and placebo-controlled clinical trial
    Khadivi, Aida
    Shobeiri, Parnian
    Momtazmaneh, Sara
    Samsami, Farhaneh-Sadat
    Shalbafan, Mohammadreza
    Shirazi, Elham
    Akhondzadeh, Shahin
    PSYCHOPHARMACOLOGY, 2022, 239 (02) : 551 - 559
  • [40] Efficacy and Safety of Agomelatine in the Treatment of Major Depressive Disorder A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
    Zajecka, John
    Schatzberg, Alan
    Stahl, Stephen
    Shah, Amy
    Caputo, Angelika
    Post, Anke
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2010, 30 (02) : 135 - 144
12345